AstraZeneca Pharma India wins CDSCO permission to import breast cancer drug Datverzo
Bangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, Government of India to import for sale and distribution…
Astrazeneca Pharma gains after Q3 PAT soars to Rs 55 cr
Astrazeneca Pharma India advanced 1.21% to Rs 7557.05 after the company’s standalone net profit surged to Rs 54.68 crore in Q3 FY 25 as compared with Rs 15.80 crore in…









